OMRON Healthcare Co., Ltd. announced new initiatives to accelerate its global electrocardiogram (ECG) business strategy, ...

Secures FDA 510(K) Clearance For 12-Lead ECG Synthesis Software Following Successful Appeal. HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through ...

HeartBeam’s ECG software duplicates the 12-lead ECG approach undertaken in healthcare settings with electrodes to evaluate ...

HeartBeam's 1st synthesized 12-lead ECG cleared by FDA, enabling cable-free at-home arrhythmia assessment with launch set for 2026.

HeartBeam shares rise after FDA clears its 12-lead ECG software, boosting plans for a 2026 launch and expanded cardiac ...

Unlike any single-lead or 6-lead consumer device, HeartBeam's patented cable-free technology captures the heart's electrical signals in three non-coplanar dimensions and synthesizes them into a ...

LAS CRUCES, NEW MEXICO / ACCESS Newswire / December 2, 2025 / Following CMS’s announcement of the new ACCESS Model (Advancing ...

A screenshot from a video demonstrating how to use the HeartBeam ECG device. HeartBeam (Nasdaq:BEAT) announced today that it received FDA 510(k) clearance for its 12-lead electrocardiogram (ECG) ...

Background The cross-sectional association between cerebral tissue oxygen saturation (SctO2) and heart failure (HF) has been previously studied, but the prognostic significance of SctO2 in HF remains ...

The device measures blood pressure, pulse, oxygen levels, and heart rate. Bangkok Hospital Headquarters has launched the ...

Allied Market Research published a report, titled, " Cardiovascular Diagnostic Device Market by Type (Electrocardiogram ...

Faraz Ahmad, MD, and Marie-Noelle Langan, MD, discuss the role of artificial intelligence (AI) for cardiac care within healthcare systems.